Advantages and disadvantages of laparoscopic access for pelvic exenteration in patients with locally advanced rectal cancer (a meta-analysis and a systematic review)
https://doi.org/10.33878/2073-7556-2025-24-3-194-200
Abstract
AIM: pelvic exenteration is a surgical procedure for locally advanced pelvic organ cancer in order to achieve optimal resection margins. The expediency of performing such operations with laparoscopic access is controversial. A meta-analysis was done to evaluate the effectiveness of laparoscopic pelvic exenterations for rectal cancer.
MATERIALS AND METHODS: a systematic review was conducted in accordance with PRISMA practices and recommendations. Literature search was carried out in the electronic medical literature databases PubMed and eLibrary. According to a meta-analysis of 4 original studies, the results of treatment of 220 patients who underwent laparoscopic exenteration and 311 patients who underwent open surgery were evaluated.
RESULTS: significant differences were obtained in the reduction of intraoperative blood loss by 427 ml, 95% CI, p = 0.0004, and postoperative hospital stay by 2 days, 95% CI, p = 0.003 in the laparoscopic group. Comparable data were obtained for the operation time, p = 0.45, for the positive margin of resection (OR 0.85; 95% CI 0.19–3.93; p = 0.84), for the postoperative morbidity (OR 0.62; 95% CI 0.23–1.86; p = 0.34) and for surgical site infections (OR 0.56; 95% CI 0.18–1.64; p = 0.29).
CONCLUSION: laparoscopic exenterations are comparable in operation time to open procedure, reduce intraoperative blood loss and postoperative hospital stay days.
About the Authors
A. A. BalkarovRussian Federation
Artyom A. Balkarov.
Salyama Adilya st., 2, 123423, Moscow
S. V. Chernyshov
Russian Federation
Stanislav V. Chernyshov.
Salyama Adilya st., 2, 123423, Moscow
E. G. Rybakov
Russian Federation
Evgeny G. Rybakov.
Salyama Adilya st., 2, 123423, Moscow
M. S. Likhter
Russian Federation
Mikhail S. Likhter.
Salyama Adilya st., 2, 123423, Moscow
Yu. A. Shelygin
Russian Federation
Yuri A. Shelygin.
Salyama Adilya st., 2, 123423, Moscow; Barricadnaya st., 2/1, Moscow, 123995
References
1. The PelvEx Collaborative. Minimally invasive surgery techniques in pelvic exenteration: a systematic and meta-analysis review. Surg Endosc. 32, 4707–4715 (2018). doi: 10.1007/s00464-018-6299-5
2. Sychev S.I., Rybakov E.G., Alekseev M.V., et al. Effectiveness of the total neoadjuvant therapy in rectal cancer treatment. Results of the randomized trial. Koloproktologia. 2024;23(1):10–20. (In Russ.). doi: 10.33878/2073-7556-2024-23-1-10-20
3. Papaccio F, Roselló S, Huerta M, et al. Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer. Cancers (Basel). 2020;12(12):3611. Published 2020 Dec 3. doi: 10.3390/cancers12123611
4. Alahmadi R, Steffens D, Solomon MJ, et al. Elderly Patients Have Better Quality of Life but Worse Survival Following Pelvic Exenteration: A 25-Year Single-Center Experience. Ann Surg Oncol. 2021;28(9):5226–5235. doi: 10.1245/s10434-021-09685-6
5. Rokan Z, Simillis C, Kontovounisios C, et al. Systematic review of classification systems for locally recurrent rectal cancer. BJS Open. 2021;5(3):zrab024. doi: 10.1093/bjsopen/zrab024
6. Warps AK, Zwanenburg ES, Dekker JWT, et al. Laparoscopic Versus Open Colorectal Surgery in the Emergency Setting: A Systematic Review and Meta-analysis. Ann Surg Open. 2021;2(3):e097. Published 2021 Sep 14. doi: 10.1097/AS9.0000000000000097
7. Nussbaum DP, Speicher PJ, Ganapathi AM, et al. Laparoscopic versus open low anterior resection for rectal cancer: results from the national cancer data base. J Gastrointest Surg. 2015;19(1):124–132. doi: 10.1007/s11605-014-2614-1
8. Zhuang M, Chen H, Li Y, et al. Laparoscopic posterior pelvic exenteration is safe and feasible for locally advanced primary rectal cancer in female patients: a comparative study from China PelvEx collaborative. Tech Coloproctol. 2023;27(11):1109–1117. doi: 10.1007/s10151-023-02824-z
9. Tang JQ, Zhang JZ, Mei SW, et al. Laparoscopic versus open pelvic exenteration for locally advanced rectal cancer: analysis of short- and long-term effects. Zhonghua WeiChang WaiKeZa Zhi. 2023;26(3):253–259. doi: 10.3760/cma.j.cn441530-20230222-00049
10. Chernyshov S.V., Sychev S.I., Ponomarenko A.A., et al. Laparoscopic resections with transanal specimen extraction in rectal cancer surgery (a systematic review and meta-analysis). Koloproktologia. 2020;19(4):150–176. (In Russ.). doi: 10.33878/2073-7556-2020-19-4-150-176
11. Kazi M, Kumar NAN, Rohila J, et al. Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes. BJS Open. 2021;5(5):zrab074. doi: 10.1093/bjsopen/zrab074
12. Kumar NA, Sasi SP, Shinde RS, et al. Minimally Invasive Surgery for Pelvic Exenteration in Primary Colorectal Cancer. JSLS. 2020;24(3):e2020.00026. doi: 10.4293/JSLS.2020.00026
13. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. Published 2015 Jan 1. doi: 10.1186/2046-4053-4-1
14. Ferenschild FT, Vermaas M, Verhoef C, et al. Total pelvic exenteration for primary and recurrent malignancies. World J Surg. 2009;33(7):1502–1508. doi: 10.1007/s00268-009-0066-7
15. Puntambekar S, Rajamanickam S, Agarwal G, et al. Laparoscopic posterior exenteration in advanced gynecologic malignant disease. J Minim Invasive Gynecol. 2011;18(1):59–63. doi: 10.1016/j.jmig.2010.09.003
16. Houvenaeghel G, de Nonneville A, Blache G, et al. Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes. J Gynecol Oncol. 2022;33(3):e31. doi: 10.3802/jgo.2022.33.e31
17. Pawlik TM, Skibber JM, Rodriguez-Bigas MA. Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol. 2006;13(5):612–623. doi: 10.1245/ASO.2006.03.082
18. Gould LE, Pring ET, Drami I, et al. A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer. Int J Surg. 2022;104:106738. doi: 10.1016/j.ijsu.2022.106738
19. Pomel C, Rouzier R, Pocard M, et al. Laparoscopic total pelvic exenteration for cervical cancer relapse. Gynecol Oncol. 2003;91(3):616–618. doi: 10.1016/j.ygyno.2003.08.032
20. Yang K, Cai L, Yao L, et al. Laparoscopic total pelvic exenteration for pelvic malignancies: the technique and short-time outcome of 11 cases. World J Surg Oncol. 2015;13:301. Published 2015 Oct 15. doi: 10.1186/s12957-015-0715-2
21. Hoshino N, Fukui Y, Hida K, et al. Similarities and differences between study designs in short- and long-term outcomes of laparoscopic versus open low anterior resection for rectal cancer: A systematic review and meta-analysis of randomized, case-matched, and cohort studies. Ann Gastroenterol Surg. 2020;5(2):183–193. Published 2020 Nov 21. doi: 10.1002/ags3.12409
22. Puntambekar S, Kudchadkar RJ, Gurjar AM, et al. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases. Gynecol Oncol. 2006;102(3):513–516. doi: 10.1016/j.ygyno.2006.01.010
Review
For citations:
Balkarov A.A., Chernyshov S.V., Rybakov E.G., Likhter M.S., Shelygin Yu.A. Advantages and disadvantages of laparoscopic access for pelvic exenteration in patients with locally advanced rectal cancer (a meta-analysis and a systematic review). Koloproktologia. 2025;24(3):194-200. (In Russ.) https://doi.org/10.33878/2073-7556-2025-24-3-194-200